Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Diagnostic Kit for Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis

NCT03487861 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03487861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03487861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Diagnostic Kit for Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Unknown status
Start date
August 29, 2017
Completion date
December 31, 2020
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney allograft fibrosis, kidney transplant failure and rejection